Will Ozempic be ranked within the top three prescribed drugs for diabetes by June 30, 2024?
20
Ṁ21kJun 21
2%
chance
1D
1W
1M
ALL
This market resolves to 'yes' if market reports or pharmaceutical tracking studies published by IQVIA, the National Prescription Audit (NPA), or the Centers for Medicare & Medicaid Services (CMS) before or on June 30, 2024, rank Ozempic among the top three prescribed drugs for diabetes. The resolution source will be the publicly available reports from these specified organizations. The market end date is June 30, 2024.
Get Ṁ1,000 play money
Related questions
Related questions
How much will Ozempic cost in 2027 in the USA?
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
11% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
66% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
43% chance
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
75% chance
Will there be a recall of Wegovy/Ozempic before 2035?
62% chance
Will Steve austad regularly try ozempic by EOY 2028
41% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will Kim Jong Un start taking Ozempic (or any GLP-1) by the end of 2025?
20% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance